4//SEC Filing
FROESEL DAVID W JR 4
Accession 0001127602-10-029626
CIK 0001014739other
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 2:58 PM ET
Size
7.8 KB
Accession
0001127602-10-029626
Insider Transaction Report
Form 4
BioScrip, Inc.BIOS
FROESEL DAVID W JR
Chief Financial Officer
Transactions
- Award
Stock Appreciation Right
2010-12-01+200,000→ 200,000 totalExercise: $4.49From: 2011-12-01Exp: 2020-12-01→ Common Stock, $.0001 Par Value (200,000 underlying) - Award
Employee Stock Option
2010-12-01+200,000→ 200,000 totalExercise: $4.49From: 2011-12-01Exp: 2020-12-01→ Common Stock, $.0001 Par Value (200,000 underlying)
Footnotes (2)
- [F1]Vests and becomes exercisable in three equal annual installments commencing on the first anniversary of the date of grant.
- [F2]Each unit represents a cash-based phantom stock appreciation right exercisable for the cash amount, if any, by which the closing stock price on the exercise date exceeds $4.49.
Documents
Issuer
BioScrip, Inc.
CIK 0001014739
Entity typeother
Related Parties
1- filerCIK 0001224636
Filing Metadata
- Form type
- 4
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 2:58 PM ET
- Size
- 7.8 KB